Skip to main content
Erschienen in: Calcified Tissue International 5/2008

01.05.2008

Collagen Cross-Linking Influences Osteoblastic Differentiation

verfasst von: C. Turecek, N. Fratzl-Zelman, M. Rumpler, B. Buchinger, S. Spitzer, R. Zoehrer, E. Durchschlag, K. Klaushofer, E. P. Paschalis, F. Varga

Erschienen in: Calcified Tissue International | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Osteoblasts synthesize collagen matrix, which itself regulates the differentiation of precursor cells into mature osteoblasts. They express lysyl oxidase (LOX), which is involved in the collagen cross-linking process. Lathyrogens, like ß-aminopropionitrile (ßAPN), inhibit the formation of a stable matrix. The aim of the present study was to investigate the influence of cross-linking on osteoblastic differentiation. MC3T3-E1 cells were seeded and treated with or without 400 μM ßAPN for 1 week. Thereafter, living cells were removed and, on this extracellular matrix, new MC3T3-E1 cells were seeded and cultured for 1 week without ßAPN. RNA was isolated, and expression of specific marker genes was determined by quantitative reverse transcription-polymerase chain reaction. Changes in specific cross-links after ßAPN treatment were measured with Fourier-transform infrared spectroscopy. The collagen matrix that formed showed a significant reduction of two major cross-links of bone collagen, deH-DHLNL and pyr, compared to control cultures. Gene expression studies showed an increase of collagen α1 (I) (COL1A1) to 150%. Expression of LOX and osteocalcin (OCN) mRNA was significantly downregulated to about 75%. When fresh MC3T3-E1 cells were seeded on this altered matrix without ßAPN, COL1A1 mRNA expression was upregulated (140%), OCN was downregulated (60%), and LOX mRNA expression remained unaffected. These results indicate that ßAPN treatment not only disrupts collagen cross-link formation but also affects osteoblastic activity and expression. In conclusion, the disrupted matrix produced in the presence of lathyrogen influences, even in its absence, the expression of osteoblastic genes.
Literatur
1.
Zurück zum Zitat Prockop DJ, Sieron AL, Li SW (1998) Procollagen N-proteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling. Matrix Biol 16:399–408PubMedCrossRef Prockop DJ, Sieron AL, Li SW (1998) Procollagen N-proteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling. Matrix Biol 16:399–408PubMedCrossRef
2.
Zurück zum Zitat Knott L, Bailey AJ (1998) Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 22:181–187PubMedCrossRef Knott L, Bailey AJ (1998) Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 22:181–187PubMedCrossRef
3.
Zurück zum Zitat Anderson JJB, Garner SC (1996) Calcium and phosphorus in health and disease. CRC Press Anderson JJB, Garner SC (1996) Calcium and phosphorus in health and disease. CRC Press
4.
Zurück zum Zitat Leblond CP (1989) Synthesis and secretion of collagen by cells of connective tissue, bone, and dentin. Anat Rec 224:123–138PubMedCrossRef Leblond CP (1989) Synthesis and secretion of collagen by cells of connective tissue, bone, and dentin. Anat Rec 224:123–138PubMedCrossRef
5.
Zurück zum Zitat Acil Y, Vetter U, Brenner R, Muller PK, Brinckmann J (1995) Ehlers-Danlos syndrome type VI: cross-link pattern in tissue and urine sample as a diagnostic marker. J Am Acad Dermatol 33:522–524PubMedCrossRef Acil Y, Vetter U, Brenner R, Muller PK, Brinckmann J (1995) Ehlers-Danlos syndrome type VI: cross-link pattern in tissue and urine sample as a diagnostic marker. J Am Acad Dermatol 33:522–524PubMedCrossRef
6.
Zurück zum Zitat Liu G, Nellaiappan K, Kagan HM (1997) Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J Biol Chem 272:32370–32377PubMedCrossRef Liu G, Nellaiappan K, Kagan HM (1997) Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J Biol Chem 272:32370–32377PubMedCrossRef
7.
Zurück zum Zitat Lehmann HW, Rimek D, Bodo M, Brenner RE, Vetter U, Worsdorfer O, Karbowski A, Muller PK (1995) Hydroxylation of collagen type I: evidence that both lysyl and prolyl residues are overhydroxylated in osteogenesis imperfecta. Eur J Clin Invest 25:306–310PubMedCrossRef Lehmann HW, Rimek D, Bodo M, Brenner RE, Vetter U, Worsdorfer O, Karbowski A, Muller PK (1995) Hydroxylation of collagen type I: evidence that both lysyl and prolyl residues are overhydroxylated in osteogenesis imperfecta. Eur J Clin Invest 25:306–310PubMedCrossRef
8.
Zurück zum Zitat Raisz LG (2004) Homocysteine and osteoporotic fractures—culprit or bystander? N Engl J Med 350:2089–2090PubMedCrossRef Raisz LG (2004) Homocysteine and osteoporotic fractures—culprit or bystander? N Engl J Med 350:2089–2090PubMedCrossRef
9.
Zurück zum Zitat McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042–2049PubMedCrossRef McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042–2049PubMedCrossRef
10.
Zurück zum Zitat van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033–2041PubMedCrossRef van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033–2041PubMedCrossRef
11.
Zurück zum Zitat Gram Gjesdal C, Vollset SE, Ueland PM, Refsum H, Meyer HE, Tell GS (2007) Plasma homocysteine, folate and vitamin B12 and the risk of hip fracture. The Hordaland Homocysteine Study. J Bone Miner Res 22:747–756CrossRef Gram Gjesdal C, Vollset SE, Ueland PM, Refsum H, Meyer HE, Tell GS (2007) Plasma homocysteine, folate and vitamin B12 and the risk of hip fracture. The Hordaland Homocysteine Study. J Bone Miner Res 22:747–756CrossRef
12.
Zurück zum Zitat Luegmayr E, Varga F, Frank T, Roschger P, Klaushofer K (1996) Effects of triiodothyronine on morphology, growth behavior, and the actin cytoskeleton in mouse osteoblastic cells (MC3T3-E1). Bone 18:591–599PubMedCrossRef Luegmayr E, Varga F, Frank T, Roschger P, Klaushofer K (1996) Effects of triiodothyronine on morphology, growth behavior, and the actin cytoskeleton in mouse osteoblastic cells (MC3T3-E1). Bone 18:591–599PubMedCrossRef
13.
Zurück zum Zitat Khan M, Yamauchi M, Srisawasdi S, Stiner D, Doty S, Paschalis EP, Boskey AL (2001) Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micro-mass cultures. Bone 28:387–398PubMedCrossRef Khan M, Yamauchi M, Srisawasdi S, Stiner D, Doty S, Paschalis EP, Boskey AL (2001) Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micro-mass cultures. Bone 28:387–398PubMedCrossRef
14.
Zurück zum Zitat Sakamoto W, Isomura H, Fujie K, Deyama Y, Kato A, Nishihira J, Izumi H (2005) Homocysteine attenuates the expression of osteocalcin but enhances osteopontin in MC3T3-E1 preosteoblastic cells. Biochim Biophys Acta 1740:12–16PubMed Sakamoto W, Isomura H, Fujie K, Deyama Y, Kato A, Nishihira J, Izumi H (2005) Homocysteine attenuates the expression of osteocalcin but enhances osteopontin in MC3T3-E1 preosteoblastic cells. Biochim Biophys Acta 1740:12–16PubMed
15.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408PubMedCrossRef Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408PubMedCrossRef
16.
Zurück zum Zitat Paschalis EP, Verdelis K, Doty SB, Boskey AL, Mendelsohn R, Yamauchi M (2001) Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res 16:1821–1828PubMedCrossRef Paschalis EP, Verdelis K, Doty SB, Boskey AL, Mendelsohn R, Yamauchi M (2001) Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res 16:1821–1828PubMedCrossRef
17.
Zurück zum Zitat Byler D, Susi H (1986) Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers 25:469–487PubMedCrossRef Byler D, Susi H (1986) Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers 25:469–487PubMedCrossRef
18.
Zurück zum Zitat Fratzl-Zelman N, Horandner H, Luegmayr E, Varga F, Ellinger A, Erlee MP, Klaushofer K (1997) Effects of triiodothyronine on the morphology of cells and matrix, the localization of alkaline phosphatase, and the frequency of apoptosis in long-term cultures of MC3T3-E1 cells. Bone 20:225–236PubMedCrossRef Fratzl-Zelman N, Horandner H, Luegmayr E, Varga F, Ellinger A, Erlee MP, Klaushofer K (1997) Effects of triiodothyronine on the morphology of cells and matrix, the localization of alkaline phosphatase, and the frequency of apoptosis in long-term cultures of MC3T3-E1 cells. Bone 20:225–236PubMedCrossRef
19.
Zurück zum Zitat Hong HH, Pischon N, Santana RB, Palamakumbura AH, Chase HB, Gantz D, Guo Y, Uzel MI, Ma D, Trackman PC (2004) A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast cultures. J Cell Physiol 200:53–62PubMedCrossRef Hong HH, Pischon N, Santana RB, Palamakumbura AH, Chase HB, Gantz D, Guo Y, Uzel MI, Ma D, Trackman PC (2004) A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast cultures. J Cell Physiol 200:53–62PubMedCrossRef
20.
Zurück zum Zitat Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT (1999) Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14:893–903PubMedCrossRef Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT (1999) Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14:893–903PubMedCrossRef
21.
Zurück zum Zitat Auer J, Lamm G, Eber B (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 351:1027–1030PubMedCrossRef Auer J, Lamm G, Eber B (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 351:1027–1030PubMedCrossRef
22.
Zurück zum Zitat Blackburn GL (2004) A new risk factor for fractures? Diets low in B vitamins may leave people more prone to broken bones. Health News 10:12 Blackburn GL (2004) A new risk factor for fractures? Diets low in B vitamins may leave people more prone to broken bones. Health News 10:12
23.
Zurück zum Zitat Bursztyn M (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 351:1027–1030PubMedCrossRef Bursztyn M (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 351:1027–1030PubMedCrossRef
24.
Zurück zum Zitat Ellenberg SS, Orloff DG, Temple RJ (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 351:1027–1030PubMedCrossRef Ellenberg SS, Orloff DG, Temple RJ (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 351:1027–1030PubMedCrossRef
25.
Zurück zum Zitat Perez-Castrillon JL, Arranz-Pena ML, Luis DD (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 351:1027–1030PubMedCrossRef Perez-Castrillon JL, Arranz-Pena ML, Luis DD (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 351:1027–1030PubMedCrossRef
26.
Zurück zum Zitat Cashman KD (2005) Homocysteine and osteoporotic fracture risk: a potential role for B vitamins. Nutr Rev 63:29–36PubMedCrossRef Cashman KD (2005) Homocysteine and osteoporotic fracture risk: a potential role for B vitamins. Nutr Rev 63:29–36PubMedCrossRef
27.
Zurück zum Zitat Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA (2005) Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 20:921–929PubMedCrossRef Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA (2005) Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 20:921–929PubMedCrossRef
28.
Zurück zum Zitat Herrmann M, Widmann T, Herrmann W (2005) Homocysteine—a newly recognised risk factor for osteoporosis. Clin Chem Lab Med 43:1111–1117PubMedCrossRef Herrmann M, Widmann T, Herrmann W (2005) Homocysteine—a newly recognised risk factor for osteoporosis. Clin Chem Lab Med 43:1111–1117PubMedCrossRef
29.
Zurück zum Zitat Jamal SA, Leiter RE, Bauer DC (2005) Hyperhomocysteinemia and aortic calcification are associated with fractures in patients on haemodialysis. QJM 98:575–579PubMedCrossRef Jamal SA, Leiter RE, Bauer DC (2005) Hyperhomocysteinemia and aortic calcification are associated with fractures in patients on haemodialysis. QJM 98:575–579PubMedCrossRef
30.
Zurück zum Zitat Morris MS, Jacques PF, Selhub J (2005) Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 37:234–242PubMedCrossRef Morris MS, Jacques PF, Selhub J (2005) Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 37:234–242PubMedCrossRef
31.
Zurück zum Zitat Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Homocysteine as a predictive factor for hip fracture in stroke patients. Bone 36:721–726PubMedCrossRef Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Homocysteine as a predictive factor for hip fracture in stroke patients. Bone 36:721–726PubMedCrossRef
32.
Zurück zum Zitat Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson’s disease. Am J Med 118:1250–1255PubMedCrossRef Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson’s disease. Am J Med 118:1250–1255PubMedCrossRef
33.
Zurück zum Zitat van Meurs JB, Uitterlinden AG (2005) Homocysteine and fracture prevention. JAMA 293:1121–1122PubMedCrossRef van Meurs JB, Uitterlinden AG (2005) Homocysteine and fracture prevention. JAMA 293:1121–1122PubMedCrossRef
34.
Zurück zum Zitat Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Drevon CA, Gjessing HK, Tell GS (2006) Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 166:88–94PubMedCrossRef Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Drevon CA, Gjessing HK, Tell GS (2006) Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 166:88–94PubMedCrossRef
35.
Zurück zum Zitat Herrmann W (2006) Significance of hyperhomocysteinemia. Clin Lab 52:367–374PubMed Herrmann W (2006) Significance of hyperhomocysteinemia. Clin Lab 52:367–374PubMed
36.
Zurück zum Zitat Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, Lee KU, Kim GS (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21:1003–1011PubMedCrossRef Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, Lee KU, Kim GS (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21:1003–1011PubMedCrossRef
37.
Zurück zum Zitat Saito M, Fujii K, Marumo K (2006) Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 79:160–168PubMedCrossRef Saito M, Fujii K, Marumo K (2006) Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 79:160–168PubMedCrossRef
38.
Zurück zum Zitat Selhub J (2006) The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 136:1726S–1730SPubMed Selhub J (2006) The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 136:1726S–1730SPubMed
39.
Zurück zum Zitat Gerdhem P, Ivaska KK, Isaksson A, Pettersson K, Vaananen HK, Obrant KJ, Akesson K (2007) Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 22:127–134PubMedCrossRef Gerdhem P, Ivaska KK, Isaksson A, Pettersson K, Vaananen HK, Obrant KJ, Akesson K (2007) Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 22:127–134PubMedCrossRef
40.
Zurück zum Zitat Roblin X, Phelip JM, Genevois M, Ducros V, Bonaz B (2007) Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn’s disease. Aliment Pharmacol Ther 25:797–804PubMedCrossRef Roblin X, Phelip JM, Genevois M, Ducros V, Bonaz B (2007) Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn’s disease. Aliment Pharmacol Ther 25:797–804PubMedCrossRef
41.
Zurück zum Zitat Masse PG, Colombo VE, Gerber F, Howell DS, Weiser H (1990) Morphological abnormalities in vitamin B6 deficient tarsometatarsal chick cartilage. Scanning Microsc 4:667–674PubMed Masse PG, Colombo VE, Gerber F, Howell DS, Weiser H (1990) Morphological abnormalities in vitamin B6 deficient tarsometatarsal chick cartilage. Scanning Microsc 4:667–674PubMed
42.
Zurück zum Zitat Masse PG, Boskey AL, Pritzker KPH, Mendes M, Weiser H (1994) Vitamin B6 deficiency experimentally-induced bone and joint disorder: microscopic, radiographic and biochemical evidence. Br J Nutr 71:919–932PubMedCrossRef Masse PG, Boskey AL, Pritzker KPH, Mendes M, Weiser H (1994) Vitamin B6 deficiency experimentally-induced bone and joint disorder: microscopic, radiographic and biochemical evidence. Br J Nutr 71:919–932PubMedCrossRef
43.
Zurück zum Zitat Masse PG, Rimnac CM, Yamauchi M, Coburn PS, Rucker BR, Howell SD, Boskey AL (1996) Pyridoxine deficiency affects biomechanical properties of chick tibial bone. Bone 18:567–574PubMedCrossRef Masse PG, Rimnac CM, Yamauchi M, Coburn PS, Rucker BR, Howell SD, Boskey AL (1996) Pyridoxine deficiency affects biomechanical properties of chick tibial bone. Bone 18:567–574PubMedCrossRef
44.
Zurück zum Zitat Khan M, Yamauchi M, Srisawasdi S, Stiner D, Doty S, Paschalis EP, Boskey AL (2001) Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micro-mass cultures. Bone 28:387–398PubMedCrossRef Khan M, Yamauchi M, Srisawasdi S, Stiner D, Doty S, Paschalis EP, Boskey AL (2001) Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micro-mass cultures. Bone 28:387–398PubMedCrossRef
45.
Zurück zum Zitat Oxlund H, Mosekilde L, Ortoft G (1996) Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone 19:479–484PubMedCrossRef Oxlund H, Mosekilde L, Ortoft G (1996) Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone 19:479–484PubMedCrossRef
Metadaten
Titel
Collagen Cross-Linking Influences Osteoblastic Differentiation
verfasst von
C. Turecek
N. Fratzl-Zelman
M. Rumpler
B. Buchinger
S. Spitzer
R. Zoehrer
E. Durchschlag
K. Klaushofer
E. P. Paschalis
F. Varga
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
Calcified Tissue International / Ausgabe 5/2008
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-008-9136-3

Weitere Artikel der Ausgabe 5/2008

Calcified Tissue International 5/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.